OCUL logo

Ocular Therapeutix (OCUL) Retained Earnings

Annual Retained Earnings

-$697.58 M
-$80.74 M-13.09%

December 31, 2023


Summary


Performance

OCUL Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCULbalance sheetmetrics:

Quarterly Retained Earnings

-$842.70 M
-$36.49 M-4.53%

September 30, 2024


Summary


Performance

OCUL Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCULbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

OCUL Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.1%-26.1%
3 y3 years-29.4%-55.5%
5 y5 years-134.7%-135.7%

OCUL Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-27.8%at low-54.4%at low
5 y5-year-81.8%at low-119.7%at low
alltimeall time-1369.7%at low-1286.5%at low

Ocular Therapeutix Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$842.70 M(+4.5%)
Jun 2024
-
-$806.20 M(+5.7%)
Mar 2024
-
-$762.43 M(+9.3%)
Dec 2023
-$697.58 M(+13.1%)
-$697.58 M(+4.4%)
Sep 2023
-
-$668.36 M(+0.1%)
Jun 2023
-
-$667.84 M(+3.2%)
Mar 2023
-
-$647.16 M(+4.9%)
Dec 2022
-$616.84 M(+13.0%)
-$616.84 M(+2.6%)
Sep 2022
-
-$601.30 M(+4.2%)
Jun 2022
-
-$577.11 M(+3.4%)
Mar 2022
-
-$558.35 M(+2.3%)
Dec 2021
-$545.80 M(+1.2%)
-$545.80 M(+0.7%)
Sep 2021
-
-$541.95 M(-0.5%)
Jun 2021
-
-$544.61 M(+1.6%)
Mar 2021
-
-$536.13 M(-0.6%)
Dec 2020
-$539.25 M(+40.6%)
-$539.25 M(+18.9%)
Sep 2020
-
-$453.64 M(+2.7%)
Jun 2020
-
-$441.69 M(+9.0%)
Mar 2020
-
-$405.13 M(+5.6%)
Dec 2019
-$383.62 M
-$383.62 M(+7.3%)
Sep 2019
-
-$357.60 M(+5.5%)
Jun 2019
-
-$338.82 M(+7.8%)
DateAnnualQuarterly
Mar 2019
-
-$314.37 M(+5.8%)
Dec 2018
-$297.24 M(+25.3%)
-$297.24 M(+6.2%)
Sep 2018
-
-$279.84 M(+5.7%)
Jun 2018
-
-$264.83 M(+5.5%)
Mar 2018
-
-$251.03 M(+5.8%)
Dec 2017
-$237.26 M(+36.5%)
-$237.26 M(+5.8%)
Sep 2017
-
-$224.16 M(+7.5%)
Jun 2017
-
-$208.60 M(+9.8%)
Mar 2017
-
-$189.90 M(+9.2%)
Dec 2016
-$173.88 M(+34.6%)
-$173.88 M(+8.0%)
Sep 2016
-
-$161.06 M(+6.3%)
Jun 2016
-
-$151.46 M(+8.2%)
Mar 2016
-
-$140.02 M(+8.4%)
Dec 2015
-$129.18 M(+44.4%)
-$129.18 M(+9.0%)
Sep 2015
-
-$118.54 M(+10.8%)
Jun 2015
-
-$107.02 M(+10.3%)
Mar 2015
-
-$97.01 M(+8.5%)
Dec 2014
-$89.43 M(+47.1%)
-$89.43 M(+9.8%)
Sep 2014
-
-$81.47 M(+9.8%)
Jun 2014
-
-$74.18 M(+9.4%)
Mar 2014
-
-$67.79 M(+11.5%)
Dec 2013
-$60.78 M(+28.1%)
-$60.78 M
Dec 2012
-$47.46 M
-

FAQ

  • What is Ocular Therapeutix annual retained earnings?
  • What is the all time high annual retained earnings for Ocular Therapeutix?
  • What is Ocular Therapeutix annual retained earnings year-on-year change?
  • What is Ocular Therapeutix quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Ocular Therapeutix?
  • What is Ocular Therapeutix quarterly retained earnings year-on-year change?

What is Ocular Therapeutix annual retained earnings?

The current annual retained earnings of OCUL is -$697.58 M

What is the all time high annual retained earnings for Ocular Therapeutix?

Ocular Therapeutix all-time high annual retained earnings is -$47.46 M

What is Ocular Therapeutix annual retained earnings year-on-year change?

Over the past year, OCUL annual retained earnings has changed by -$80.74 M (-13.09%)

What is Ocular Therapeutix quarterly retained earnings?

The current quarterly retained earnings of OCUL is -$842.70 M

What is the all time high quarterly retained earnings for Ocular Therapeutix?

Ocular Therapeutix all-time high quarterly retained earnings is -$60.78 M

What is Ocular Therapeutix quarterly retained earnings year-on-year change?

Over the past year, OCUL quarterly retained earnings has changed by -$174.34 M (-26.08%)